Found: 46
Select item for more details and to access through your institution.
Kinetics of molecular recurrence after tyrosine kinase inhibitor cessation in chronic phase chronic myelogenous leukaemia patients.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 4, p. 1536, doi. 10.1111/bjh.19330
- By:
- Publication type:
- Article
Efficacy and safety of nilotinib in chronic myeloid leukaemia patients who failed to achieve a treatment‐free remission period after imatinib discontinuation: Results of the French Nilo post‐STIM study.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 6, p. 1116, doi. 10.1111/bjh.18796
- By:
- Publication type:
- Article
Dasatinib plus Peg‐Interferon alpha 2b combination in newly diagnosed chronic phase chronic myeloid leukaemia: Results of a multicenter phase 2 study (DASA‐PegIFN study).
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 2, p. 175, doi. 10.1111/bjh.18486
- By:
- Publication type:
- Article
Dasatinib dose optimisation based on therapeutic drug monitoring reduces pleural effusion rates in chronic myeloid leukaemia patients.
- Published in:
- British Journal of Haematology, 2021, v. 194, n. 2, p. 393, doi. 10.1111/bjh.17654
- By:
- Publication type:
- Article
A single center evaluation of cost savings related to treatment‐free remission in chronic myeloid leukemia patients: the prerequisites of a pharmaco‐economy larger study.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 3, p. e97, doi. 10.1111/bjh.16511
- By:
- Publication type:
- Article
Risk of molecular recurrence after tyrosine kinase inhibitor discontinuation in chronic myeloid leukaemia patients: a systematic review of literature with a meta‐analysis of studies over the last ten years.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 3, p. 452, doi. 10.1111/bjh.16408
- By:
- Publication type:
- Article
Nilotinib efficacy, safety, adherence and impact on quality of life in newly diagnosed patients with chronic myeloid leukaemia in chronic phase: a prospective observational study in daily clinical practice.
- Published in:
- British Journal of Haematology, 2019, v. 187, n. 5, p. 615, doi. 10.1111/bjh.16145
- By:
- Publication type:
- Article
Impact of ELN recommendations in the management of first-line treated chronic myeloid leukaemia patients: a French cross-sectional study.
- Published in:
- British Journal of Haematology, 2016, v. 174, n. 1, p. 71, doi. 10.1111/bjh.14022
- By:
- Publication type:
- Article
Impact of second decline rate of BCR-ABL1 transcript on clinical outcome of chronic phase chronic myeloid leukemia patients on imatinib first-line.
- Published in:
- 2019
- By:
- Publication type:
- journal article
One-Year Follow-Up of Seroprevalence of SARS-CoV-2 Infection and Anxiety among Health Workers of a French Cancer Center: The PRO-SERO-COV Study.
- Published in:
- International Journal of Environmental Research & Public Health, 2023, v. 20, n. 11, p. 5949, doi. 10.3390/ijerph20115949
- By:
- Publication type:
- Article
Proteomic analysis of an imatinib-resistant K562 cell line highlights opposing roles of heat shock cognate 70 and heat shock 70 proteins in resistance.
- Published in:
- Proteomics, 2008, v. 8, n. 12, p. 2394, doi. 10.1002/pmic.200701035
- By:
- Publication type:
- Article
A Multicenter Retrospective Chart Review Study of Treatment and Disease Patterns and Clinical Outcomes of Patients with Chronic-Phase Chronic Myeloid Leukemia in Third-Line Treatment or with T315I Mutation.
- Published in:
- Cancers, 2023, v. 15, n. 16, p. 4161, doi. 10.3390/cancers15164161
- By:
- Publication type:
- Article
Definition, Epidemiology, Pathophysiology, and Essential Criteria for Diagnosis of Pediatric Chronic Myeloid Leukemia.
- Published in:
- Cancers, 2021, v. 13, n. 4, p. 798, doi. 10.3390/cancers13040798
- By:
- Publication type:
- Article
Incidences of Deep Molecular Responses and Treatment-Free Remission in de Novo CP-CML Patients.
- Published in:
- Cancers, 2020, v. 12, n. 9, p. 2521, doi. 10.3390/cancers12092521
- By:
- Publication type:
- Article
DNA methylation profiling reveals a pathological signature that contributes to transcriptional defects of CD34<sup>+</sup>CD15<sup>−</sup> cells in early chronic‐phase chronic myeloid leukemia.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 6, p. 814, doi. 10.1002/1878-0261.12191
- By:
- Publication type:
- Article
Type of recurrence is associated with disease-free survival after salvage surgery for locally recurrent rectal cancer.
- Published in:
- International Journal of Colorectal Disease, 2021, v. 36, n. 12, p. 2603, doi. 10.1007/s00384-021-03998-4
- By:
- Publication type:
- Article
Second‐ or third‐generation tyrosine kinase inhibitors in first‐line treatment of chronic myeloid leukemia in general population: Is there a real benefit?
- Published in:
- Cancer Medicine, 2021, v. 10, n. 20, p. 6959, doi. 10.1002/cam4.4186
- By:
- Publication type:
- Article
Relevance of treatment‐free remission recommendations in chronic phase chronic leukemia patients treated with frontline tyrosine kinase inhibitors.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 11, p. 3635, doi. 10.1002/cam4.3921
- By:
- Publication type:
- Article
Incidence and outcome of BCR‐ABL mutated chronic myeloid leukemia patients who failed to tyrosine kinase inhibitors.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 11, p. 5173, doi. 10.1002/cam4.2410
- By:
- Publication type:
- Article
Killer immunoglobulin‐like receptor genotypes and chronic myeloid leukemia outcomes after imatinib cessation for treatment‐free remission.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 11, p. 4976, doi. 10.1002/cam4.2371
- By:
- Publication type:
- Article
The Lotus Flower: Black students learning and loving through the anti‐Black labyrinth of higher ed.
- Published in:
- Canadian Review of Sociology, 2021, v. 58, n. 3, p. 443, doi. 10.1111/cars.12354
- By:
- Publication type:
- Article
Life-threatening adverse drug reactions at admission to medical intensive care: a prospective study in a teaching hospital.
- Published in:
- 2007
- By:
- Publication type:
- journal article
α-defensin 1-3 and α-defensin 4 as predictive markers of imatinib resistance and relapse in CML patients.
- Published in:
- Disease Markers, 2011, v. 30, n. 5, p. 221, doi. 10.1155/2011/287690
- By:
- Publication type:
- Article
CML-413: Asciminib Provides Durable Responses and a Favorable Safety Profile in Patients with Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) with the T315I Mutation in a Phase 1 Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S335, doi. 10.1016/S2152-2650(21)01784-5
- By:
- Publication type:
- Article
Poster: CML-413: Asciminib Provides Durable Responses and a Favorable Safety Profile in Patients with Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) with the T315I Mutation in a Phase 1 Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S224, doi. 10.1016/S2152-2650(21)01409-9
- By:
- Publication type:
- Article
Efficacy and Safety of Asciminib, a Specific Allosteric BCR-ABL1 Inhibitor Targeting the Myristoyl-Binding Site, in Patients with Chronic Myeloid Leukemia (CML) Carrying the T315I Mutation.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S289, doi. 10.1016/j.clml.2019.07.234
- By:
- Publication type:
- Article
Effect of Dose Modifications on Response to Duvelisib in Patients with Relapsed/Refractory (R/R) CLL/SLL in the DUO Trial.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S273, doi. 10.1016/j.clml.2019.07.204
- By:
- Publication type:
- Article
Long-Term Follow-Up of De Novo Chronic Phase Chronic Myelogenous Leukemia Patients on Imatinib First-Line.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S306, doi. 10.1016/j.clml.2017.07.103
- By:
- Publication type:
- Article
Novel analytical methods to interpret large sequencing data from small sample sizes.
- Published in:
- Human Genomics, 2019, v. 13, n. 1, p. N.PAG, doi. 10.1186/s40246-019-0235-1
- By:
- Publication type:
- Article
Efficiency of nilotinib to target chronic phase-chronic myeloid leukaemia primary mature CD34− and immature CD34+ cells.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-85734-0
- By:
- Publication type:
- Article
A collaborative review of the microsatellite instability/deficient mismatch repair phenotype in patients with upper tract urothelial carcinoma.
- Published in:
- BJU International, 2024, v. 134, n. 5, p. 723, doi. 10.1111/bju.16405
- By:
- Publication type:
- Article
Sensitisation of cancer cells to radiotherapy by serine and glycine starvation.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Efficacy and tolerance of hyperthermic intravesical chemotherapy (HIVEC) according to the number of instillations administered.
- Published in:
- World Journal of Urology, 2024, v. 42, n. 1, p. 1, doi. 10.1007/s00345-024-05219-3
- By:
- Publication type:
- Article
Perioperative, renal function and oncological outcomes of robot-assisted radical nephroureterectomy for patients with upper tract urothelial carcinoma.
- Published in:
- World Journal of Urology, 2023, v. 41, n. 11, p. 3001, doi. 10.1007/s00345-023-04590-x
- By:
- Publication type:
- Article
Impact of eculizumab treatment on paroxysmal nocturnal hemoglobinuria: a treatment versus no-treatment study.
- Published in:
- American Journal of Hematology, 2016, v. 91, p. 366, doi. 10.1002/ajh.24278
- By:
- Publication type:
- Article
Impact of eculizumab treatment on paroxysmal nocturnal hemoglobinuria: a treatment versus no-treatment study.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 4, p. 366, doi. 10.1002/ajh.24278
- By:
- Publication type:
- Article
ELN 2013 response status criteria: Relevance for de novo imatinib chronic phase chronic myeloid leukemia patients?
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 1, p. 37, doi. 10.1002/ajh.23864
- By:
- Publication type:
- Article
A SIN lentiviral vector containing piga cdna allows long-term phenotypic correction of CD34<sup>+</sup>-derived cells from patients with paroxysmal nocturnal hemoglobinuria
- Published in:
- Molecular Therapy, 2003, v. 7, n. 3, p. 304, doi. 10.1016/S1525-0016(03)00011-X
- By:
- Publication type:
- Article
A Claudin-Based Molecular Signature Identifies High-Risk, Chemoresistant Colorectal Cancer Patients.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 9, p. 2211, doi. 10.3390/cells10092211
- By:
- Publication type:
- Article
UTILISATION DES SIG ET DE LA TELEDETECTION POUR LA CARTOGRAPHIE DE LA SUSCEPTIBILITE AUX MOUVEMENTS D'INSTABILITE DE VERSANT DANS L'OUEST MONTAGNEUX DE LA CÔTE D'IVOIRE.
- Published in:
- Revue Francaise de Photogrammetrie et de Teledetection, 2020, p. 1
- By:
- Publication type:
- Article
Diagnostic et gestion des effets secondaires pleuropulmonaires des inhibiteurs de tyrosine kinase Recommandations du Groupe français pour la leucémie myéloïde chronique.
- Published in:
- Hematologie, 2018, v. 24, n. 2, p. 134, doi. 10.1684/hma.2018.1362
- By:
- Publication type:
- Article
Discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia: Recommendations for clinical practice from the French Chronic Myeloid Leukemia Study Group.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Second tyrosine kinase inhibitor discontinuation attempt in patients with chronic myeloid leukemia.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Pioglitazone together with imatinib in chronic myeloid leukemia: A proof of concept study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Bortezomib combined with low-dose cytarabine in Intermediate-2 and high risk myelodysplastic syndromes. A phase I/ II Study by the GFM.
- Published in:
- British Journal of Haematology, 2012, v. 158, n. 2, p. 232, doi. 10.1111/j.1365-2141.2012.09153.x
- By:
- Publication type:
- Article
The CJEU's Unintelligible Impairment of the Financial Health of EU Performers: Ever-Increasing Suspense in Neighbouring Rights.
- Published in:
- GRUR International: Journal of European & International IP Law, 2024, v. 73, n. 9, p. 850, doi. 10.1093/grurint/ikae077
- By:
- Publication type:
- Article